Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6556)
All Articles published online
|
Publishing Process of This Article
|
Mar 21, 2015 (publication date) through Apr 18, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Baki E, Zwickel P, Zawierucha A, Ehehalt R, Gotthardt D, Stremmel W, Gauss A. Real-life outcome of anti-tumor necrosis factor α in the ambulatory treatment of ulcerative colitis. World J Gastroenterol 2015; 21(11): 3282-3290 [PMID: 25805935 DOI: 10.3748/wjg.v21.i11.3282] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i11/3282.htm |
| Number | Citing Articles |
| 1 |
Nathalie C. Gemayel, Eugenio Rizzello, Petar Atanasov, Daniel Wirth, Andras Borsi. Dose escalation and switching of biologics in ulcerative colitis: a systematic literature review in real-world evidence. Current Medical Research and Opinion 2019; 35(11): 1911 doi: 10.1080/03007995.2019.1631058
|
| 2 |
|
| 3 |
C. Fradet, J. Kern, P. Atanasov, D. Wirth, A. Borsi. Impact of surgery and its complications in ulcerative colitis patients in clinical practice: A systematic literature review of real-world evidence in Europe. International Journal of Surgery Open 2020; 22: 22 doi: 10.1016/j.ijso.2019.11.010
|
| 4 |
Erika Lehtola, Johanna Haapamäki, Martti A. Färkkilä. Outcome of inflammatory bowel disease patients treated with TNF-α inhibitors: two-year follow-up. Scandinavian Journal of Gastroenterology 2016; 51(12): 1476 doi: 10.1080/00365521.2016.1218539
|
| 5 |
Daniel J Wong, Eve M Roth, Joseph D Feuerstein, Vitaliy Y Poylin. Surgery in the age of biologics. Gastroenterology Report 2019; 7(2): 77 doi: 10.1093/gastro/goz004
|
| 6 |
Yuka Marutani, Tsutomu Mizoshita, Tomoya Sugiyama, Shozo Togawa, Takahito Katano, Tomonori Yamada, Yoshikazu Hirata, Yoshihide Kimura, Tomokatsu Miyaki, Yusuke Inoue, Erina Suzuki, Makoto Sasaki, Hiromi Kataoka. Efficacies of first and second tumor necrosis factor inhibitors in refractory ulcerative colitis patients in real-world practice. Indian Journal of Gastroenterology 2020; 39(6): 565 doi: 10.1007/s12664-020-01092-1
|
| 7 |
Salvatore Bellinvia, J. R. Fraser Cummings, Michael R. Ardern-Jones, Christopher J. Edwards. Adalimumab Biosimilars in Europe: An Overview of the Clinical Evidence. BioDrugs 2019; 33(3): 241 doi: 10.1007/s40259-019-00355-4
|
| 8 |
Antonio Tursi, Walter Elisei, Roberto Faggiani, Leonardo Allegretta, Nicola Della Valle, Giacomo Forti, Marilisa Franceschi, Antonio Ferronato, Sara Gallina, Tiziana Larussa, Francesco Luzza, Roberto Lorenzetti, Giammarco Mocci, Antonio Penna, Stefano Rodino’, Ladislava Sebkova, Antonio de Medici, Giuseppe Pranzo, Cristina Ricciardelli, Giuseppina Grasso, Stefano Scorza, Costantino Zampaletta, Marcello Picchio. Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis. Medicine 2018; 97(34): e11897 doi: 10.1097/MD.0000000000011897
|
| 9 |
Natsuki Ishida, Kenichi Takahashi, Yusuke Asai, Takahiro Miyazu, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Ken Sugimoto, Emiko Mizoguchi. Albumin change predicts failure in ulcerative colitis treated with adalimumab. PLOS ONE 2024; 19(1): e0295681 doi: 10.1371/journal.pone.0295681
|
| 10 |
Christopher M. Black, Eric Yu, Eilish McCann, Sumesh Kachroo, Laszlo Gulacsi. Dose Escalation and Healthcare Resource Use among Ulcerative Colitis Patients Treated with Adalimumab in English Hospitals: An Analysis of Real-World Data. PLOS ONE 2016; 11(2): e0149692 doi: 10.1371/journal.pone.0149692
|
| 11 |
Laura Guberna, Olga P. Nyssen, María Chaparro, Javier P. Gisbert. Frequency and Effectiveness of Empirical Anti-TNF Dose Intensification in Inflammatory Bowel Disease: Systematic Review with Meta-Analysis. Journal of Clinical Medicine 2021; 10(10): 2132 doi: 10.3390/jcm10102132
|
| 12 |
Harpreet Singh, Liam Wilson, Tom Tencer, Jinender Kumar. Systematic Literature Review of Real-World Evidence on Dose Escalation and Treatment Switching in Ulcerative Colitis. ClinicoEconomics and Outcomes Research 2023; : 125 doi: 10.2147/CEOR.S391413
|
| 13 |
Vito Annese, Rahul Nathwani, Maryam Alkhatry, Ahmad Al-Rifai, Sameer Al Awadhi, Filippos Georgopoulos, Ahmad N. Jazzar, Ahmed M. Khassouan, Zaher Koutoubi, Mazen S. Taha, Jimmy K. Limdi. Optimizing biologic therapy in inflammatory bowel disease: a Delphi consensus in the United Arab Emirates. Therapeutic Advances in Gastroenterology 2021; 14: 175628482110653 doi: 10.1177/17562848211065329
|
| 14 |
Fernando Magro, Rish K Pai, Taku Kobayashi, Vipul Jairath, Florian Rieder, Isabel Redondo, Trevor Lissoos, Nathan Morris, Mingyang Shan, Meekyong Park, Laurent Peyrin-Biroulet. Resolving Histological Inflammation in Ulcerative Colitis With Mirikizumab in the LUCENT Induction and Maintenance Trial Programmes. Journal of Crohn's and Colitis 2023; 17(9): 1457 doi: 10.1093/ecco-jcc/jjad050
|
| 15 |
Bernd Bokemeyer, Nils Picker, Daniel Kromer, Ludger Rosin, Haridarshan Patel. Rates of clinical remission and inadequate response to advanced therapies among patients with ulcerative colitis in Germany. International Journal of Colorectal Disease 2023; 38(1) doi: 10.1007/s00384-023-04397-7
|
| 16 |
Bernadette Pöllinger, Wolfgang Schmidt, Anna Seiffert, Heidi Imhoff, Martin Emmert. Costs of dose escalation among ulcerative colitis patients treated with adalimumab in Germany. The European Journal of Health Economics 2019; 20(2): 195 doi: 10.1007/s10198-017-0953-z
|
| 17 |
Marta Maia Bosca-Watts, Xavier Cortes, Marisa Iborra, Jose Maria Huguet, Laura Sempere, Gloria Garcia, Rafa Gil, MariFe Garcia, Marga Muñoz, Pedro Almela, Nuria Maroto, Jose Maria Paredes. Short-term effectiveness of golimumab for ulcerative colitis: Observational multicenter study. World Journal of Gastroenterology 2016; 22(47): 10432-10439 doi: 10.3748/wjg.v22.i47.10432
|
| 18 |
Marie Muller, Ferdinando D’Amico, Stefanos Bonovas, Silvio Danese, Laurent Peyrin-Biroulet. TNF Inhibitors and Risk of Malignancy in Patients with Inflammatory Bowel Diseases: A Systematic Review. Journal of Crohn's and Colitis 2021; 15(5): 840 doi: 10.1093/ecco-jcc/jjaa186
|
| 19 |
Kymberley Thorne, Laith Alrubaiy, Ashley Akbari, David G. Samuel, Sian Morrison-Rees, Stephen E. Roberts. Colectomy rates in patients with ulcerative colitis following treatment with infliximab or ciclosporin. European Journal of Gastroenterology & Hepatology 2016; 28(4): 369 doi: 10.1097/MEG.0000000000000568
|